Literature DB >> 22415664

Significance of histomorphology of early triple-negative breast cancer.

Gábor Rubovszky1, Zsolt Horváth, Erika Tóth, István Láng, Miklós Kásler.   

Abstract

UNLABELLED: Triple-negative breast cancer (TNBC) is a heterogeneous disease. Possibly genetic characterisation provides the most appropriate information on tumour biology and prognosis, but it is only limitedly available in clinical practice. The aim of this investigation was to explore what additional prognostic information could be gained from detailed histomorphologic report. PATIENTS AND
METHOD: patients were selected retrospectively operated from 2005 to 2009 in one institution and charts were revised. Beyond age, tumour and nodal status, histologic grade and therapy, the additional pathologic characteristics were also involved in analysis: necrosis, lymphocytic infiltration, peritumoural vascular invasion (PVI), perineural invasion, DCIS extent and grade, perinodal spread, mitotic activity index (MAI).
RESULTS: 295 early TNBC were involved. In univariate survival analysis with a mean follow-up of 3.57 years the tumour size, the nodal status, type of operation (conservation or mastectomy), irradiation, PVI and perinodal spread proved to be significantly connected with both disease free survival (DFS) and breast cancer specific overall survival (BSOS), and necrosis and chemotherapy with BSOS. Necrosis analysed together with lymphocytic infiltrate showed greater predicting power. In multivariate analysis nodal metastasis, necrosis positive/lymphacytic infiltration negative status and lack of irradiation has significant negative impact on DFS (p = <0.0001 HR:1.98 [1.4-2.77], p = <0.017 HR:2.1 [1.1-3.8], p = <0.001 HR:0.25 [0.11-0.57], respectively) and BSOS (p = <0.0001 HR:2.47 [1.8-3.4], p = <0.017 HR:3.7 [1.6-8.2], p = <0.0017 HR:0.24 [0.1-0.58], respectively). For DFS perivascular invasion also showed significant effect (p = <0.042 HR:2.5 [1.0-6.0]). Nodal status was the strongest prognostic parameter but other histomorphologic parameters can be used for prognosis prediction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415664     DOI: 10.1007/s12253-012-9510-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  32 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers.

Authors:  F-C Bidard; R Conforti; T Boulet; S Michiels; S Delaloge; F André
Journal:  Ann Oncol       Date:  2007-07       Impact factor: 32.976

4.  Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients.

Authors:  Suzanne C Schiffman; Kelly M McMasters; Charles R Scoggins; Robert C Martin; Anees B Chagpar
Journal:  J Am Coll Surg       Date:  2011-05-20       Impact factor: 6.113

5.  Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.

Authors:  Renaud Sabatier; Jocelyne Jacquemier; François Bertucci; Benjamin Esterni; Pascal Finetti; Francine Azario; Daniel Birnbaum; Patrice Viens; Anthony Gonçalves; Jean-Marc Extra
Journal:  Eur J Cancer       Date:  2011-03-08       Impact factor: 9.162

6.  Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland.

Authors:  A Spitale; P Mazzola; D Soldini; L Mazzucchelli; A Bordoni
Journal:  Ann Oncol       Date:  2008-12-12       Impact factor: 32.976

7.  Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

Authors:  G Viale; A Giobbie-Hurder; B A Gusterson; E Maiorano; M G Mastropasqua; A Sonzogni; E Mallon; M Colleoni; M Castiglione-Gertsch; M M Regan; K N Price; R W Brown; R Golouh; D Crivellari; P Karlsson; C Öhlschlegel; R D Gelber; A Goldhirsch; A S Coates
Journal:  Ann Oncol       Date:  2009-07-24       Impact factor: 32.976

8.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up.

Authors:  S E Pinder; I O Ellis; M Galea; S O'Rouke; R W Blamey; C W Elston
Journal:  Histopathology       Date:  1994-01       Impact factor: 5.087

9.  Triple negative phenotype and N-ratio are important for prognosis in patients with stage IIIB non-inflammatory breast carcinoma.

Authors:  Hakan Mersin; Emin Yildirim; Ugur Berberoglu; Kaptan Gulben
Journal:  J Surg Oncol       Date:  2009-12-15       Impact factor: 3.454

10.  Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

Authors:  B K Linderholm; H Hellborg; U Johansson; G Elmberger; L Skoog; J Lehtiö; R Lewensohn
Journal:  Ann Oncol       Date:  2009-06-23       Impact factor: 32.976

View more
  1 in total

1.  Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Authors:  Yoon Yang Jung; Chang Lim Hyun; Min-Sun Jin; In Ae Park; Yul Ri Chung; Bobae Shim; Kyu Ho Lee; Han Suk Ryu
Journal:  J Breast Cancer       Date:  2016-09-23       Impact factor: 3.588

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.